AuraVax Therapeutics, Inc., a company developing novel immunotherapies to prevent and treat respiratory pathogens, today ...

AuraVax collaborates with Codagenix Inc. to demonstrate NanoSTING-002 with intranasal live-attenuated vaccines ... as a candidate for a pandemic influenza vaccine. The two companies will test ...

The global sales of attenuated vaccines are projected to soar, with an estimated worth of USD 5,068.2 million in 2024 and anticipated to reach USD 9,693.9 million by 2034. This growth trajectory ...

The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...

Influenza A is the most common variant of the flu and the one you’re most likely to get during pregnancy. A flu shot is the ...

The first influenza vaccine was a monovalent live-attenuated vaccine, which was used in Russia until recently. In 1940, a second strain of influenza virus was isolated; this was named influenza B ...

Aug. 15, 2024 — A unique influenza vaccine candidate that's inhaled ... vaccine with nasal spray administration of a novel attenuated live flu virus appears to be safe and ...

a pneumococcal conjugate vaccine, and a live attenuated influenza vaccine. As a Senior Vice President at Wyeth Pharmaceuticals, Bruce was responsible for all late phase development activities in Wyeth ...

That's true for influenza vaccine ... particularly for a live attenuated (weakened) vaccine, which would yield better immunity. BPZE1 is such a nasally administered live vaccine in development.

An epidemiologist makes the case that a rush of research to stop a swine flu outbreak led to an accidental lab release of an ...